CytoReason vs Ibex Medical Analytics
CytoReason vs Ibex Medical Analytics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Ibex Medical Analytics on 64/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 64/100
Ibex Medical Analytics
- agent readiness: 31/100 against 21/100
- domain rating: 52/100 against 40/100
- headcount growth: +17.3% against +13.7%
At a glance
| Measure | CytoReason | Ibex Medical Analytics |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | AI-powered platform for cancer diagnostics in digital pathology. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Medical Imaging, Pathology, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2017 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Ibex Medical Analytics |
|---|---|---|
| Employees | 116 | 99 |
| Headcount growthLast 12 months | +13.7% | +17.3% |
| Total funding | $128M | $104M |
| Latest round | Series B | Series C |
| LinkedIn followers | 12,830 | 14,109 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Ibex Medical Analytics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 64/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 30/100 | 34/100 |
| Quality | 78/100 | 70/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 52/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Ibex Medical Analytics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| Analytics | Segment | Not detected |
CytoReason vs Ibex Medical Analytics: common questions
Which is better, CytoReason or Ibex Medical Analytics?
On our 0-100 score CytoReason rates higher (68/100 against 64/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do CytoReason and Ibex Medical Analytics compare on the numbers?
CytoReason leads on our overall score (68/100 against 64/100). Ibex Medical Analytics leads on agent readiness (31/100 against 21/100), domain rating (52/100 against 40/100), headcount growth (+17.3% against +13.7%).
Read the full CytoReason review and pricing or the Ibex Medical Analytics review and pricing. You can also browse other CytoReason alternatives we track.